Published September 9, 2013 | Version Accepted Version
Journal Article Open

Use of a palladium(II)-catalyzed oxidative kinetic resolution in synthetic efforts toward bielschowskysin

  • 1. ROR icon California Institute of Technology

Abstract

Progress toward the cyclobutane core of bielshowskysin is reported. The core was thought to arise from a cyclopropane intermediate via a furan-mediated cyclopropane fragmentation, followed by a 1,4-Michael addition. The synthesis of the cyclopropane intermediate utilizes a Suzuki coupling reaction, an esterification with 2-diazoacetoacetic acid, and a copper catalyzed cyclopropanation. An alcohol intermediate within the synthetic route was obtained in high enantiopurity via a highly selective palladium(II)-catalyzed oxidative kinetic resolution (OKR).

Additional Information

© 2013 Elsevier Ltd. Received 18 December 2012; Received in revised form 8 February 2013; Accepted 8 February 2013; Available online 19 February 2013. The authors are grateful to the NIH-NIGMS (R01GM080269), the Bristol-Myers Squibb Company (predoctoral fellowship to E.M.F.), California Institute of Technology, A. P. Sloan Foundation, the Dreyfus Foundation, Research Corporation, Abbott (d), Amgen, AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Johnson and Johnson, Eli Lilly, Merck, Novartis, Pfizer, and Roche for generous funding.

Attached Files

Accepted Version - nihms447820.pdf

Files

nihms447820.pdf

Files (4.8 MB)

Name Size
md5:f66bcbee7f2a6f816bddb73925fa207c
4.8 MB Preview Download

Additional details

Identifiers

PMCID
PMC3728638
Eprint ID
41655
Resolver ID
CaltechAUTHORS:20131003-103642590

Funding

NIH
R01GM080269
Bristol-Myers Squibb Company
Caltech
Alfred P. Sloan Foundation
Camille and Henry Dreyfus Foundation
Research Corporation
Abbott
Amgen
AstraZeneca
Boehringer-Ingelheim
GlaxoSmithKline
Johnson and Johnson
Eli Lilly
Merck
Novartis
Pfizer
Roche

Dates

Created
2013-10-03
Created from EPrint's datestamp field
Updated
2021-11-10
Created from EPrint's last_modified field